| RYECX | VENAX | RYECX / VENAX | |
| Total Expense Ratio | 2.39 | 0.09 | 2,656% |
| Annual Report Gross Expense Ratio | 2.44 | 0.09 | 2,711% |
| Fund Existence | 25 years | 22 years | - |
| Gain YTD | 40.359 | 42.553 | 95% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 100000 | 3% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 27.5M | 12.4B | 0% |
| Annual Yield % from dividends | 2.59 | 2.40 | 108% |
| Returns for 1 year | 49.74 | 48.08 | 103% |
| Returns for 3 years | 44.74 | 46.44 | 96% |
| Returns for 5 years | 168.02 | 181.39 | 93% |
| Returns for 10 years | 66.48 | 85.74 | 78% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MYICX | 11.70 | 0.10 | +0.86% |
| NYLI WMC International Research Eq Cl C | |||
| RYCPX | 65.84 | 0.39 | +0.60% |
| Rydex Consumer Products C | |||
| MIGHX | 40.64 | 0.20 | +0.49% |
| MFS Massachusetts Inv Gr Stk R3 | |||
| FBTCX | 38.52 | N/A | N/A |
| Fidelity Advisor Biotechnology C | |||
| ARYWX | 14.82 | -0.02 | -0.13% |
| American Century Global Real Estate R | |||